Grandview Asset Management LLC Exact Sciences Corp Transaction History

Grandview Asset Management LLC

  • $175 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Jan 28, 2020
SELL
$77.66 - $99.74 $757,029 - $972,265
-9,748 Closed
0 $0
Q3 2019

Nov 07, 2019
BUY
$90.37 - $122.49 $709,404 - $961,546
7,850 Added 413.59%
9,748 $869,000
Q2 2019

Jul 18, 2019
BUY
$89.51 - $118.04 $169,889 - $224,039
1,898 New
1,898 $224,000

Others Institutions Holding EXAS

# of Institutions
672
Shares Held
163M
Call Options Held
2.58M
Put Options Held
2.19M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.9B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Grandview Asset Management LLC Portfolio

Follow Grandview Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Grandview Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Grandview Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email